Utility of ELISA Optical Density Values and Clinical Scores for the Diagnosis of and Thrombosis Prediction in Heparin-induced Thrombocytopenia
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction caused by antibodies to the heparin/platelet factor 4 (PF4) complex, resulting in thrombocytopenia and prothrombotic state. HIT diagnosis is challenging and depends on clinical presentation and laboratory tests. We investigated the usefulness of clinical scores and heparin/PF4 ELISA optical density (OD) as a diagnostic marker and thrombosis predictor in HIT. Methods: We analyzed 92 patients with suspected HIT. The heparin/PF4 antibody was measured using a commercial ELISA kit (GTI,USA). For each patient, the 4 T’s score and Chong’s score were calculated. Results: Of the 92 patients, 28 were anti-heparin/PF4-seropositive. The 4 T’s score and Chong’s score showed good correlation (r=0.874). The 4 T’s score and OD values showed good performance for diagnosis of the definite and unlikely HIT groups; however, OD levels showed better sensitivity (93.8%) than the 4 T’s score used alone (62.5%). Of the 92 patients, 26 developed thrombosis. The OD values were significantly higher in patients with thrombosis than in those without thrombosis (0.52 vs. 0.22, P<0.001). Patients with high OD values (OD>0.4) had an increased risk of thrombosis (adjusted odds ratio 9.44 [3.35–26.6], P<0.001) and a shorter 250-day thrombosis-free survival (32.1% vs. 54.7%, P=0.012). Conclusions: ELISA OD values in combination with clinical scoring can improve the diagnosis of and thrombosis prediction in HIT. More attention should be paid to the use of clinical scores and OD values as thrombosis predictors in HIT.
Abstract
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction caused by antibodies to the heparin/platelet factor 4 (PF4) complex, resulting in thrombocytopenia and prothrombotic state. HIT diagnosis is challenging and depends on clinical presentation and laboratory tests. We investigated the usefulness of clinical scores and heparin/PF4 ELISA optical density (OD) as a diagnostic marker and thrombosis predictor in HIT. Methods: We analyzed 92 patients with suspected HIT. The heparin/PF4 antibody was measured using a commercial ELISA kit (GTI,USA). For each patient, the 4 T’s score and Chong’s score were calculated. Results: Of the 92 patients, 28 were anti-heparin/PF4-seropositive. The 4 T’s score and Chong’s score showed good correlation (r=0.874). The 4 T’s score and OD values showed good performance for diagnosis of the definite and unlikely HIT groups; however, OD levels showed better sensitivity (93.8%) than the 4 T’s score used alone (62.5%). Of the 92 patients, 26 developed thrombosis. The OD values were significantly higher in patients with thrombosis than in those without thrombosis (0.52 vs. 0.22, P<0.001). Patients with high OD values (OD>0.4) had an increased risk of thrombosis (adjusted odds ratio 9.44 [3.35–26.6], P<0.001) and a shorter 250-day thrombosis-free survival (32.1% vs. 54.7%, P=0.012). Conclusions: ELISA OD values in combination with clinical scoring can improve the diagnosis of and thrombosis prediction in HIT. More attention should be paid to the use of clinical scores and OD values as thrombosis predictors in HIT.
참고문헌 (16)
- Greinacher A, "Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update", Thromb Res, 118, pp.165~176 (2006)
- Chong BH, "Heparin-induced thrombocytopenia", Expert Rev Cardiovasc Ther, 2, pp.547~559 (2004)
- Warkentin TE, "Laboratory diagnosis of immune heparin-induced thrombocytopenia", Curr Hematol Rep, 2, pp.148~157 (2003)
- Lo GK, "Evaluation of pretest clinical score(4 T’s)for the diagnosis of heparin-induced thrombocytopenia in two clinical settings", J Thromb Haemost, 4, pp.759~765 (2006)
- Greinacher A, "Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4", heparin antibodies of the IgG, IgM, and IgA classes, 2007, pp.5, 1666~1673
- Warkentin TE, "Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?", J Lab Clin Med, 146, pp.341~346 (2005)
- Zwicker JI, "Thrombosis and ELISA optical density values in hospitalized patients with heparininduced thrombocytopenia", J Thromb Haemost, 2, pp.2133~2137 (2004)
- Warkentin TE, "Heparin-induced thrombocytopenia:recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy", Chest, 126, pp.311~337 (2004)
- Bakchoul T, "Prospective evaluation of PF4", heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia, 2009, pp.7, 1260~1265
- Bryant A, "Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T’s score and particle gel immunoassay", Br J Haematol, 143, pp.721~726 (2008)
- Janatpour KA, "Usefulness of optical density values from heparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia", Am J Clin Pathol, 127, pp.429~433 (2007)
- Whitlatch NL, "Anti-heparin", platelet factor 4antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia, 2008, pp.100, 678~684
- Weiss BM, "Optical density values correlate with the clinical probability of heparin induced thrombocytopenia", J Thromb Thrombolysis, 26, pp.243~247 (2008)
- Warkentin TE, "Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays", J Thromb Haemost, 6, pp.1304~1312 (2008)
- Mattioli AV, "Thrombotic events in patients with antiplatelet factor 4", heparin antibodies, 2009, pp.95, 1350~1354
- Warkentin TE, "Impact of the patient population on the risk for heparin-induced thrombocytopenia", Blood, 96, pp.1703~1708 (2000)